ARTICLES BY THIS AUTHOR
- 2/6/2020
Cardinal Health posts 5% revenue growth in Q2
Cardinal Health's second-quarter revenue for the pharmaceutical segment was $35.7 billion, a hike of 6% from the same period last year. - 2/6/2020
FDA clears 1st treatment for peanut allergy in children
The FDA has approved Palforzia, the first treatment for peanut allergy in children. - 2/6/2020
Coronavirus fears drive shortages of respiratory masks, sanitizers
The spread of the coronavirus is leading to a shortage of masks and sanitizers in retailers nationwide. - 2/5/2020
Independent Pharmacy Conference celebrates 10 years
The Independent Pharmacy Conference, now in its 10th year, provides a meeting place for independent owners, industry leaders and vendors. - 2/5/2020
Fresenius Kabi introduces Glucagon Emergency Kit
Fresenius Kabi's glucagon emergency kit provides a treatment for severe hypoglycemia in pediatric and adult patients with diabetes. - 2/5/2020
Hy-Vee offers free biometric screenings
Hy-Vee dietitians working out of Hy-Vee Healthy You Mobiles will offer free biometric screenings to customers at 91 Hy-Vee stores - 2/5/2020
Lupin gets FDA blessing for generic Arava
Leflunomide tablets had a market value of roughly $44 million, according to December 2019 IQVIA data. - 2/4/2020
Augia Pharma gets FDA nod for generic Rheumatrex
Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. - 2/4/2020
McKesson sees revenue gains in Q3
McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion. - 2/4/2020
NACDS' Anderson addresses coronavirus and pharmacists' readiness in op-ed
Pharmacists are committed to responding to public health emergencies such as the coronavirus, and patients' needs every day, NACDS' Steve Anderson writes in an op-ed on Medium.